Serological biomarkers reflecting collagen remodeling of the tumor microenvironment are elevated in metastatic colorectal cancer

Stephanie Nina Kehlet, R. Sanz-Pamplona, D. J. Leeming, M.A. Karsdal, V. Moreno

Research output: Contribution to conference › Conference abstract for conference › Research › peer-review

Original language	English
Publication date	2016
Number of pages	2
Publication status	Published - 2016
Event	The Function of Tumor Microenvironment in Cancer Progression - San Diego, United States Duration: 7 Jan 2016 → 10 Jan 2016

Conference	The Function of Tumor Microenvironment in Cancer Progression
Country/Territory	United States
City	San Diego
Period	07/01/2016 → 10/01/2016

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

@conference{9215e227904f4d458dd59b46d21aaff0,

title = "Serological biomarkers reflecting collagen remodeling of the tumor microenvironment are elevated in metastatic colorectal cancer",

author = "Kehlet, {Stephanie Nina} and R. Sanz-Pamplona and Leeming, {D. J.} and M.A. Karsdal and V. Moreno",

year = "2016",

language = "English",

note = "The Function of Tumor Microenvironment in Cancer Progression ; Conference date: 07-01-2016 Through 10-01-2016",

}

Serological biomarkers reflecting collagen remodeling of the tumor microenvironment are elevated in metastatic colorectal cancer. / Kehlet, Stephanie Nina; Sanz-Pamplona, R.; Leeming, D. J. et al.
2016. Abstract from The Function of Tumor Microenvironment in Cancer Progression, San Diego, California, United States.

Research output: Contribution to conference › Conference abstract for conference › Research › peer-review

TY - ABST

T1 - Serological biomarkers reflecting collagen remodeling of the tumor microenvironment are elevated in metastatic colorectal cancer

AU - Kehlet, Stephanie Nina

AU - Sanz-Pamplona, R.

AU - Leeming, D. J.

AU - Karsdal, M.A.

AU - Moreno, V.

PY - 2016

Y1 - 2016

M3 - Conference abstract for conference

T2 - The Function of Tumor Microenvironment in Cancer Progression

Y2 - 7 January 2016 through 10 January 2016

ER -